Effect of subanesthetic dose of esketamine on postoperative rehabilitation in elderly patients undergoing hip arthroplasty

The majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group frequently exhibits perioperative symptoms of pain, anxiety, and sadness, which extends recovery time to some extent. Esketamine, the right-handed monomer of ke...

Full description

Saved in:
Bibliographic Details
Published inJournal of orthopaedic surgery and research Vol. 18; no. 1; pp. 268 - 7
Main Authors Min, Menghang, Du, Chengxu, Chen, Xiaoying, Xin, Wenqi
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 03.04.2023
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group frequently exhibits perioperative symptoms of pain, anxiety, and sadness, which extends recovery time to some extent. Esketamine, the right-handed monomer of ketamine, is more popular these days due to its sedative, analgesic, and antidepressant properties. There are currently few domestic and international research on the use of esketamine in elderly individuals who have undergone surgery for a femoral neck fracture. In order to further cut the length of the hospital stay and hasten postoperative recovery, this study investigates whether esketamine postoperative analgesia can lessen postoperative pain, anxiety, and depression in older patients having hip replacement. 150 patients, ASA physical status I-II, aged ≥ 60 years, no limitation in gender, BMI 18-25 kg/cm , who underwent selective total hip arthroplasty, according to random number table method, esketamine group (group A) and sufentanil group (group B) were randomized, 75 patients in each group. The two groups received general anesthesia method. At the end of the operation, PCIA was connected for analgesia. In group A, esketamine 2.5 mg/kg was mixed with normal saline to 100 ml. In group B, sufentanil 2.5 ug/kg was mixed with normal saline to 100 ml. Record the VAS scores after operation. Record the first ambulation time, ambulation distance and Patient-controlled Analgesia compression times after operation. The incidence of postoperative adverse reactions such as drowsiness, dizziness, nausea and vomiting, multilingual were recorded. ELISA was used to detect IL-6 and CRP in the morning, 24 h and 72 h after operation. The Hospital Anxiety and Depression Scale (HAD) score and Harris score at 3 days, 1 week and 1 month after operation were followed up. There was no significant difference in VAS score and PCA compression times (P > 0.05), but the incidence of nausea, vomiting and dizziness in group B was higher than that in group A (P < 0.05). Compared with group B, the levels of IL-6 and CRP in group A at 24 h and 72 h after operation were significantly decreased (P < 0.05). Postoperative ambulation time and ambulation distance in group A were better than those in group B (P < 0.05). The HAD score of group A was lower than that of group B at 3 days and 1 week after operation (P < 0.05). However, there was no significant difference between the two groups at 1 month after operation (P > 0.05). The Harris score of group A was higher than that of group B at 3 days, 1 week and 1 month after operation (P < 0.05). Esketamine can reduce short-term postoperative anxiety and depression, relieve postoperative pain and stress response, shorten bed rest time after total hip replacement, and accelerate postoperative recovery.
AbstractList The majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group frequently exhibits perioperative symptoms of pain, anxiety, and sadness, which extends recovery time to some extent. Esketamine, the right-handed monomer of ketamine, is more popular these days due to its sedative, analgesic, and antidepressant properties. There are currently few domestic and international research on the use of esketamine in elderly individuals who have undergone surgery for a femoral neck fracture. In order to further cut the length of the hospital stay and hasten postoperative recovery, this study investigates whether esketamine postoperative analgesia can lessen postoperative pain, anxiety, and depression in older patients having hip replacement. 150 patients, ASA physical status I-II, aged ≥ 60 years, no limitation in gender, BMI 18-25 kg/cm , who underwent selective total hip arthroplasty, according to random number table method, esketamine group (group A) and sufentanil group (group B) were randomized, 75 patients in each group. The two groups received general anesthesia method. At the end of the operation, PCIA was connected for analgesia. In group A, esketamine 2.5 mg/kg was mixed with normal saline to 100 ml. In group B, sufentanil 2.5 ug/kg was mixed with normal saline to 100 ml. Record the VAS scores after operation. Record the first ambulation time, ambulation distance and Patient-controlled Analgesia compression times after operation. The incidence of postoperative adverse reactions such as drowsiness, dizziness, nausea and vomiting, multilingual were recorded. ELISA was used to detect IL-6 and CRP in the morning, 24 h and 72 h after operation. The Hospital Anxiety and Depression Scale (HAD) score and Harris score at 3 days, 1 week and 1 month after operation were followed up. There was no significant difference in VAS score and PCA compression times (P > 0.05), but the incidence of nausea, vomiting and dizziness in group B was higher than that in group A (P < 0.05). Compared with group B, the levels of IL-6 and CRP in group A at 24 h and 72 h after operation were significantly decreased (P < 0.05). Postoperative ambulation time and ambulation distance in group A were better than those in group B (P < 0.05). The HAD score of group A was lower than that of group B at 3 days and 1 week after operation (P < 0.05). However, there was no significant difference between the two groups at 1 month after operation (P > 0.05). The Harris score of group A was higher than that of group B at 3 days, 1 week and 1 month after operation (P < 0.05). Esketamine can reduce short-term postoperative anxiety and depression, relieve postoperative pain and stress response, shorten bed rest time after total hip replacement, and accelerate postoperative recovery.
The majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group frequently exhibits perioperative symptoms of pain, anxiety, and sadness, which extends recovery time to some extent. Esketamine, the right-handed monomer of ketamine, is more popular these days due to its sedative, analgesic, and antidepressant properties. There are currently few domestic and international research on the use of esketamine in elderly individuals who have undergone surgery for a femoral neck fracture. In order to further cut the length of the hospital stay and hasten postoperative recovery, this study investigates whether esketamine postoperative analgesia can lessen postoperative pain, anxiety, and depression in older patients having hip replacement. 150 patients, ASA physical status I-II, aged [greater than or equal to] 60 years, no limitation in gender, BMI 18-25 kg/cm.sup.2, who underwent selective total hip arthroplasty, according to random number table method, esketamine group (group A) and sufentanil group (group B) were randomized, 75 patients in each group. The two groups received general anesthesia method. At the end of the operation, PCIA was connected for analgesia. In group A, esketamine 2.5 mg/kg was mixed with normal saline to 100 ml. In group B, sufentanil 2.5 ug/kg was mixed with normal saline to 100 ml. Record the VAS scores after operation. Record the first ambulation time, ambulation distance and Patient-controlled Analgesia compression times after operation. The incidence of postoperative adverse reactions such as drowsiness, dizziness, nausea and vomiting, multilingual were recorded. ELISA was used to detect IL-6 and CRP in the morning, 24 h and 72 h after operation. The Hospital Anxiety and Depression Scale (HAD) score and Harris score at 3 days, 1 week and 1 month after operation were followed up. There was no significant difference in VAS score and PCA compression times (P > 0.05), but the incidence of nausea, vomiting and dizziness in group B was higher than that in group A (P < 0.05). Compared with group B, the levels of IL-6 and CRP in group A at 24 h and 72 h after operation were significantly decreased (P < 0.05). Postoperative ambulation time and ambulation distance in group A were better than those in group B (P < 0.05). The HAD score of group A was lower than that of group B at 3 days and 1 week after operation (P < 0.05). However, there was no significant difference between the two groups at 1 month after operation (P > 0.05). The Harris score of group A was higher than that of group B at 3 days, 1 week and 1 month after operation (P < 0.05). Esketamine can reduce short-term postoperative anxiety and depression, relieve postoperative pain and stress response, shorten bed rest time after total hip replacement, and accelerate postoperative recovery.
Abstract Objective The majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group frequently exhibits perioperative symptoms of pain, anxiety, and sadness, which extends recovery time to some extent. Esketamine, the right-handed monomer of ketamine, is more popular these days due to its sedative, analgesic, and antidepressant properties. There are currently few domestic and international research on the use of esketamine in elderly individuals who have undergone surgery for a femoral neck fracture. In order to further cut the length of the hospital stay and hasten postoperative recovery, this study investigates whether esketamine postoperative analgesia can lessen postoperative pain, anxiety, and depression in older patients having hip replacement. Methods 150 patients, ASA physical status I–II, aged ≥ 60 years, no limitation in gender, BMI 18–25 kg/cm2, who underwent selective total hip arthroplasty, according to random number table method, esketamine group (group A) and sufentanil group (group B) were randomized, 75 patients in each group. The two groups received general anesthesia method. At the end of the operation, PCIA was connected for analgesia. In group A, esketamine 2.5 mg/kg was mixed with normal saline to 100 ml. In group B, sufentanil 2.5 ug/kg was mixed with normal saline to 100 ml. Record the VAS scores after operation. Record the first ambulation time, ambulation distance and Patient-controlled Analgesia compression times after operation. The incidence of postoperative adverse reactions such as drowsiness, dizziness, nausea and vomiting, multilingual were recorded. ELISA was used to detect IL-6 and CRP in the morning, 24 h and 72 h after operation. The Hospital Anxiety and Depression Scale (HAD) score and Harris score at 3 days, 1 week and 1 month after operation were followed up. Results There was no significant difference in VAS score and PCA compression times (P > 0.05), but the incidence of nausea, vomiting and dizziness in group B was higher than that in group A (P < 0.05). Compared with group B, the levels of IL-6 and CRP in group A at 24 h and 72 h after operation were significantly decreased (P < 0.05). Postoperative ambulation time and ambulation distance in group A were better than those in group B (P < 0.05). The HAD score of group A was lower than that of group B at 3 days and 1 week after operation (P < 0.05). However, there was no significant difference between the two groups at 1 month after operation (P > 0.05). The Harris score of group A was higher than that of group B at 3 days, 1 week and 1 month after operation (P < 0.05). Conclusions Esketamine can reduce short-term postoperative anxiety and depression, relieve postoperative pain and stress response, shorten bed rest time after total hip replacement, and accelerate postoperative recovery.
Objective The majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group frequently exhibits perioperative symptoms of pain, anxiety, and sadness, which extends recovery time to some extent. Esketamine, the right-handed monomer of ketamine, is more popular these days due to its sedative, analgesic, and antidepressant properties. There are currently few domestic and international research on the use of esketamine in elderly individuals who have undergone surgery for a femoral neck fracture. In order to further cut the length of the hospital stay and hasten postoperative recovery, this study investigates whether esketamine postoperative analgesia can lessen postoperative pain, anxiety, and depression in older patients having hip replacement. Methods 150 patients, ASA physical status I-II, aged [greater than or equal to] 60 years, no limitation in gender, BMI 18-25 kg/cm.sup.2, who underwent selective total hip arthroplasty, according to random number table method, esketamine group (group A) and sufentanil group (group B) were randomized, 75 patients in each group. The two groups received general anesthesia method. At the end of the operation, PCIA was connected for analgesia. In group A, esketamine 2.5 mg/kg was mixed with normal saline to 100 ml. In group B, sufentanil 2.5 ug/kg was mixed with normal saline to 100 ml. Record the VAS scores after operation. Record the first ambulation time, ambulation distance and Patient-controlled Analgesia compression times after operation. The incidence of postoperative adverse reactions such as drowsiness, dizziness, nausea and vomiting, multilingual were recorded. ELISA was used to detect IL-6 and CRP in the morning, 24 h and 72 h after operation. The Hospital Anxiety and Depression Scale (HAD) score and Harris score at 3 days, 1 week and 1 month after operation were followed up. Results There was no significant difference in VAS score and PCA compression times (P > 0.05), but the incidence of nausea, vomiting and dizziness in group B was higher than that in group A (P < 0.05). Compared with group B, the levels of IL-6 and CRP in group A at 24 h and 72 h after operation were significantly decreased (P < 0.05). Postoperative ambulation time and ambulation distance in group A were better than those in group B (P < 0.05). The HAD score of group A was lower than that of group B at 3 days and 1 week after operation (P < 0.05). However, there was no significant difference between the two groups at 1 month after operation (P > 0.05). The Harris score of group A was higher than that of group B at 3 days, 1 week and 1 month after operation (P < 0.05). Conclusions Esketamine can reduce short-term postoperative anxiety and depression, relieve postoperative pain and stress response, shorten bed rest time after total hip replacement, and accelerate postoperative recovery. Keywords: Esketamine, Femoral neck fracture, Elderly patients, Total hip arthroplasty, Anxiety, Depression, The fascia iliaca block
The majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group frequently exhibits perioperative symptoms of pain, anxiety, and sadness, which extends recovery time to some extent. Esketamine, the right-handed monomer of ketamine, is more popular these days due to its sedative, analgesic, and antidepressant properties. There are currently few domestic and international research on the use of esketamine in elderly individuals who have undergone surgery for a femoral neck fracture. In order to further cut the length of the hospital stay and hasten postoperative recovery, this study investigates whether esketamine postoperative analgesia can lessen postoperative pain, anxiety, and depression in older patients having hip replacement.OBJECTIVEThe majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group frequently exhibits perioperative symptoms of pain, anxiety, and sadness, which extends recovery time to some extent. Esketamine, the right-handed monomer of ketamine, is more popular these days due to its sedative, analgesic, and antidepressant properties. There are currently few domestic and international research on the use of esketamine in elderly individuals who have undergone surgery for a femoral neck fracture. In order to further cut the length of the hospital stay and hasten postoperative recovery, this study investigates whether esketamine postoperative analgesia can lessen postoperative pain, anxiety, and depression in older patients having hip replacement.150 patients, ASA physical status I-II, aged ≥ 60 years, no limitation in gender, BMI 18-25 kg/cm2, who underwent selective total hip arthroplasty, according to random number table method, esketamine group (group A) and sufentanil group (group B) were randomized, 75 patients in each group. The two groups received general anesthesia method. At the end of the operation, PCIA was connected for analgesia. In group A, esketamine 2.5 mg/kg was mixed with normal saline to 100 ml. In group B, sufentanil 2.5 ug/kg was mixed with normal saline to 100 ml. Record the VAS scores after operation. Record the first ambulation time, ambulation distance and Patient-controlled Analgesia compression times after operation. The incidence of postoperative adverse reactions such as drowsiness, dizziness, nausea and vomiting, multilingual were recorded. ELISA was used to detect IL-6 and CRP in the morning, 24 h and 72 h after operation. The Hospital Anxiety and Depression Scale (HAD) score and Harris score at 3 days, 1 week and 1 month after operation were followed up.METHODS150 patients, ASA physical status I-II, aged ≥ 60 years, no limitation in gender, BMI 18-25 kg/cm2, who underwent selective total hip arthroplasty, according to random number table method, esketamine group (group A) and sufentanil group (group B) were randomized, 75 patients in each group. The two groups received general anesthesia method. At the end of the operation, PCIA was connected for analgesia. In group A, esketamine 2.5 mg/kg was mixed with normal saline to 100 ml. In group B, sufentanil 2.5 ug/kg was mixed with normal saline to 100 ml. Record the VAS scores after operation. Record the first ambulation time, ambulation distance and Patient-controlled Analgesia compression times after operation. The incidence of postoperative adverse reactions such as drowsiness, dizziness, nausea and vomiting, multilingual were recorded. ELISA was used to detect IL-6 and CRP in the morning, 24 h and 72 h after operation. The Hospital Anxiety and Depression Scale (HAD) score and Harris score at 3 days, 1 week and 1 month after operation were followed up.There was no significant difference in VAS score and PCA compression times (P > 0.05), but the incidence of nausea, vomiting and dizziness in group B was higher than that in group A (P < 0.05). Compared with group B, the levels of IL-6 and CRP in group A at 24 h and 72 h after operation were significantly decreased (P < 0.05). Postoperative ambulation time and ambulation distance in group A were better than those in group B (P < 0.05). The HAD score of group A was lower than that of group B at 3 days and 1 week after operation (P < 0.05). However, there was no significant difference between the two groups at 1 month after operation (P > 0.05). The Harris score of group A was higher than that of group B at 3 days, 1 week and 1 month after operation (P < 0.05).RESULTSThere was no significant difference in VAS score and PCA compression times (P > 0.05), but the incidence of nausea, vomiting and dizziness in group B was higher than that in group A (P < 0.05). Compared with group B, the levels of IL-6 and CRP in group A at 24 h and 72 h after operation were significantly decreased (P < 0.05). Postoperative ambulation time and ambulation distance in group A were better than those in group B (P < 0.05). The HAD score of group A was lower than that of group B at 3 days and 1 week after operation (P < 0.05). However, there was no significant difference between the two groups at 1 month after operation (P > 0.05). The Harris score of group A was higher than that of group B at 3 days, 1 week and 1 month after operation (P < 0.05).Esketamine can reduce short-term postoperative anxiety and depression, relieve postoperative pain and stress response, shorten bed rest time after total hip replacement, and accelerate postoperative recovery.CONCLUSIONSEsketamine can reduce short-term postoperative anxiety and depression, relieve postoperative pain and stress response, shorten bed rest time after total hip replacement, and accelerate postoperative recovery.
ObjectiveThe majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group frequently exhibits perioperative symptoms of pain, anxiety, and sadness, which extends recovery time to some extent. Esketamine, the right-handed monomer of ketamine, is more popular these days due to its sedative, analgesic, and antidepressant properties. There are currently few domestic and international research on the use of esketamine in elderly individuals who have undergone surgery for a femoral neck fracture. In order to further cut the length of the hospital stay and hasten postoperative recovery, this study investigates whether esketamine postoperative analgesia can lessen postoperative pain, anxiety, and depression in older patients having hip replacement.Methods150 patients, ASA physical status I–II, aged ≥ 60 years, no limitation in gender, BMI 18–25 kg/cm2, who underwent selective total hip arthroplasty, according to random number table method, esketamine group (group A) and sufentanil group (group B) were randomized, 75 patients in each group. The two groups received general anesthesia method. At the end of the operation, PCIA was connected for analgesia. In group A, esketamine 2.5 mg/kg was mixed with normal saline to 100 ml. In group B, sufentanil 2.5 ug/kg was mixed with normal saline to 100 ml. Record the VAS scores after operation. Record the first ambulation time, ambulation distance and Patient-controlled Analgesia compression times after operation. The incidence of postoperative adverse reactions such as drowsiness, dizziness, nausea and vomiting, multilingual were recorded. ELISA was used to detect IL-6 and CRP in the morning, 24 h and 72 h after operation. The Hospital Anxiety and Depression Scale (HAD) score and Harris score at 3 days, 1 week and 1 month after operation were followed up.ResultsThere was no significant difference in VAS score and PCA compression times (P > 0.05), but the incidence of nausea, vomiting and dizziness in group B was higher than that in group A (P < 0.05). Compared with group B, the levels of IL-6 and CRP in group A at 24 h and 72 h after operation were significantly decreased (P < 0.05). Postoperative ambulation time and ambulation distance in group A were better than those in group B (P < 0.05). The HAD score of group A was lower than that of group B at 3 days and 1 week after operation (P < 0.05). However, there was no significant difference between the two groups at 1 month after operation (P > 0.05). The Harris score of group A was higher than that of group B at 3 days, 1 week and 1 month after operation (P < 0.05).ConclusionsEsketamine can reduce short-term postoperative anxiety and depression, relieve postoperative pain and stress response, shorten bed rest time after total hip replacement, and accelerate postoperative recovery.
ArticleNumber 268
Audience Academic
Author Min, Menghang
Du, Chengxu
Chen, Xiaoying
Xin, Wenqi
Author_xml – sequence: 1
  givenname: Menghang
  surname: Min
  fullname: Min, Menghang
– sequence: 2
  givenname: Chengxu
  surname: Du
  fullname: Du, Chengxu
– sequence: 3
  givenname: Xiaoying
  surname: Chen
  fullname: Chen, Xiaoying
– sequence: 4
  givenname: Wenqi
  surname: Xin
  fullname: Xin, Wenqi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37009879$$D View this record in MEDLINE/PubMed
BookMark eNp9kk9r3DAQxU1Jaf60X6CHYuilF6eSLVvSqYSQJoFALy30JiR5tKutV3IlO7D99J3NbkI2lKKDpNGbn_2Gd1ochRigKN5Tck6p6D5n2hAqKlI3FWl4Lar6VXFCOZMVl_Ln0bPzcXGa84qQlrSCvSmOG06IFFyeFH-unAM7ldGVeTY6QJ6WMHlb9jHDtgr5F0x67QPeQjnGPMURkp78PZQJltr4wU94xUcfShh6SMOmHLECYcrlHLCwiD4syqUfS52mZYrjoPO0eVu8dnrI8G6_nxU_vl59v7yp7r5d315e3FW27dhUtbRuRW3ANa41YDtRt5IJQqjlAozQlFjqpDSOaUcMN6bnVmjOur5xVDLWnBW3O24f9UqNya912qiovXooxLRQ-FveDqCMpcKSRjNkMeNaaZnrdUcogBbcOWR92bHG2ayht-gx6eEAevgS_FIt4r2ihHSStA0SPu0JKf6ecdxq7bOFYcDZxzmrmkvWyYYwitKPL6SrOKeAs1K1IA3SCG5PqoVGBz64iB-2W6i64IwR2fFuqzr_hwpXD2tvMVfOY_2g4cNzp08WH6ODArET2BRzTuCU3QcByX5Ax2qbUrVLqcKUqoeUqhpb6xetj_T_NP0F0DnsTw
CitedBy_id crossref_primary_10_3389_fphar_2023_1228895
crossref_primary_10_1097_JS9_0000000000001870
crossref_primary_10_1016_j_jopan_2024_11_013
crossref_primary_10_37349_emed_2025_1001291
crossref_primary_10_1016_j_jad_2024_02_085
crossref_primary_10_1186_s12871_025_02894_6
crossref_primary_10_12677_acm_2024_1472116
crossref_primary_10_1080_03007995_2024_2331167
crossref_primary_10_1186_s12891_024_07614_8
crossref_primary_10_1186_s12871_024_02450_8
crossref_primary_10_2147_DDDT_S481173
crossref_primary_10_1097_MD_0000000000040028
crossref_primary_10_1186_s12871_024_02733_0
crossref_primary_10_1186_s13018_024_05388_2
crossref_primary_10_12677_acm_2024_14102835
crossref_primary_10_1016_j_ajp_2024_103997
crossref_primary_10_1186_s12871_023_02376_7
Cites_doi 10.1001/archinte.163.20.2433
10.1097/AAP.0000000000000808
10.1213/ANE.0000000000004833
10.1124/pr.117.015198
10.1016/0165-1781(93)90027-e
10.1016/j.jpsychores.2015.08.002
10.1016/S0924-9338(02)80212-7
10.3760/cma.j.issn.0529-5815.2019.11.002
10.1016/j.arth.2020.05.021
10.1016/j.jclinane.2020.110071
10.1016/j.bbi.2015.06.001
10.1016/j.thorsurg.2020.03.001
10.1186/s12891-017-1725-8
10.1016/j.biopsych.2015.10.018
10.3389/fsurg.2022.829303
10.2147/CIA.S113576
10.12089/jca.2022.09.008
10.1111/os.12458
10.12048/j.issn.1674-229X.2022.02.015
10.2106/00004623-199301000-00011
10.1016/j.joca.2013.08.022
ContentType Journal Article
Copyright 2023. The Author(s).
COPYRIGHT 2023 BioMed Central Ltd.
2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2023
Copyright_xml – notice: 2023. The Author(s).
– notice: COPYRIGHT 2023 BioMed Central Ltd.
– notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s13018-023-03728-2
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE



MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 1749-799X
EndPage 7
ExternalDocumentID oai_doaj_org_article_bc18c03a44af4bf59c4fda601eea87ff
PMC10069053
A744096760
37009879
10_1186_s13018_023_03728_2
Genre Randomized Controlled Trial
Journal Article
GroupedDBID ---
0R~
29L
2WC
53G
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EBD
EBLON
EBS
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
IPT
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TUS
UKHRP
WOQ
WOW
~8M
-5E
-5G
-A0
-BR
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7QP
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c564t-512582bef3f5bec6825948001c78eb8a10c1f99bf4af0b7bbd7c8a746d3f19443
IEDL.DBID M48
ISSN 1749-799X
IngestDate Wed Aug 27 01:29:46 EDT 2025
Thu Aug 21 18:38:39 EDT 2025
Sun Aug 24 04:06:27 EDT 2025
Sat Jul 26 00:03:49 EDT 2025
Tue Jun 17 21:13:15 EDT 2025
Tue Jun 10 20:47:47 EDT 2025
Thu Jan 02 22:52:18 EST 2025
Tue Jul 01 02:17:41 EDT 2025
Thu Apr 24 23:05:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Esketamine
Femoral neck fracture
The fascia iliaca block
Depression
Anxiety
Elderly patients
Total hip arthroplasty
Language English
License 2023. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c564t-512582bef3f5bec6825948001c78eb8a10c1f99bf4af0b7bbd7c8a746d3f19443
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
OpenAccessLink https://doaj.org/article/bc18c03a44af4bf59c4fda601eea87ff
PMID 37009879
PQID 2803053080
PQPubID 55349
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_bc18c03a44af4bf59c4fda601eea87ff
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10069053
proquest_miscellaneous_2794693041
proquest_journals_2803053080
gale_infotracmisc_A744096760
gale_infotracacademiconefile_A744096760
pubmed_primary_37009879
crossref_citationtrail_10_1186_s13018_023_03728_2
crossref_primary_10_1186_s13018_023_03728_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-04-03
PublicationDateYYYYMMDD 2023-04-03
PublicationDate_xml – month: 04
  year: 2023
  text: 2023-04-03
  day: 03
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of orthopaedic surgery and research
PublicationTitleAlternate J Orthop Surg Res
PublicationYear 2023
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References JB Singh (3728_CR12) 2016; 80
Li Hua (3728_CR15) 2002; 38
ZG Bi (3728_CR2) 2019; 57
T Duivenvoorden (3728_CR7) 2013; 21
P Zanos (3728_CR14) 2018; 70
Y Wang (3728_CR1) 2019; 11
TJ Gan (3728_CR18) 2020; 131
3728_CR19
X Wang (3728_CR17) 2021; 68
YM den Hartog (3728_CR6) 2017; 18
G Iolascon (3728_CR8) 2011; 8
3728_CR9
MJ Bair (3728_CR11) 2003; 163
R Haapakoski (3728_CR20) 2015; 49
P Lan (3728_CR3) 2022; 11
K Marshall (3728_CR5) 2020; 30
R Liu (3728_CR4) 2015; 79
P Zis (3728_CR10) 2017; 21
AM Schwartz (3728_CR21) 2020; 35
F Sheng (3728_CR16) 2022; 32
SP Cohen (3728_CR13) 2018; 43
References_xml – volume: 163
  start-page: 2433
  issue: 20
  year: 2003
  ident: 3728_CR11
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.163.20.2433
– volume: 43
  start-page: 521
  issue: 5
  year: 2018
  ident: 3728_CR13
  publication-title: Reg Anesth Pain Med
  doi: 10.1097/AAP.0000000000000808
– volume: 131
  start-page: 411
  issue: 2
  year: 2020
  ident: 3728_CR18
  publication-title: Anesth Analg
  doi: 10.1213/ANE.0000000000004833
– volume: 70
  start-page: 621
  year: 2018
  ident: 3728_CR14
  publication-title: Pharmacol Rev
  doi: 10.1124/pr.117.015198
– ident: 3728_CR19
  doi: 10.1016/0165-1781(93)90027-e
– volume: 79
  start-page: 574
  issue: 6
  year: 2015
  ident: 3728_CR4
  publication-title: J Psychosom Res
  doi: 10.1016/j.jpsychores.2015.08.002
– volume: 8
  start-page: 49
  issue: 3
  year: 2011
  ident: 3728_CR8
  publication-title: Clin Cases Miner Bone Metab
  doi: 10.1016/S0924-9338(02)80212-7
– volume: 57
  start-page: 804
  issue: 11
  year: 2019
  ident: 3728_CR2
  publication-title: Zhonghua Wai Ke Za Zhi
  doi: 10.3760/cma.j.issn.0529-5815.2019.11.002
– volume: 35
  start-page: 2904
  issue: 10
  year: 2020
  ident: 3728_CR21
  publication-title: J Arthroplasty
  doi: 10.1016/j.arth.2020.05.021
– volume: 68
  start-page: 110071
  year: 2021
  ident: 3728_CR17
  publication-title: J Clin Anesth
  doi: 10.1016/j.jclinane.2020.110071
– volume: 49
  start-page: 206
  year: 2015
  ident: 3728_CR20
  publication-title: Brain Behav Im mun
  doi: 10.1016/j.bbi.2015.06.001
– volume: 30
  start-page: 339
  issue: 3
  year: 2020
  ident: 3728_CR5
  publication-title: Thorac Surg Clin
  doi: 10.1016/j.thorsurg.2020.03.001
– volume: 18
  start-page: 363
  issue: 1
  year: 2017
  ident: 3728_CR6
  publication-title: BMC Musculoskelet Disord
  doi: 10.1186/s12891-017-1725-8
– volume: 80
  start-page: 424
  issue: 6
  year: 2016
  ident: 3728_CR12
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2015.10.018
– volume: 11
  start-page: 829303
  issue: 9
  year: 2022
  ident: 3728_CR3
  publication-title: Front Surg
  doi: 10.3389/fsurg.2022.829303
– volume: 21
  start-page: 709
  issue: 12
  year: 2017
  ident: 3728_CR10
  publication-title: Clin Interv Aging
  doi: 10.2147/CIA.S113576
– volume: 38
  start-page: 936
  issue: 09
  year: 2002
  ident: 3728_CR15
  publication-title: J Clin Anesthesiol
  doi: 10.12089/jca.2022.09.008
– volume: 11
  start-page: 318
  issue: 2
  year: 2019
  ident: 3728_CR1
  publication-title: Orthop Surg
  doi: 10.1111/os.12458
– volume: 32
  start-page: 150
  issue: 02
  year: 2022
  ident: 3728_CR16
  publication-title: J Med Today
  doi: 10.12048/j.issn.1674-229X.2022.02.015
– ident: 3728_CR9
  doi: 10.2106/00004623-199301000-00011
– volume: 21
  start-page: 1834
  issue: 12
  year: 2013
  ident: 3728_CR7
  publication-title: Osteoarthr Cartil
  doi: 10.1016/j.joca.2013.08.022
SSID ssj0050584
Score 2.3900986
Snippet The majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group frequently exhibits...
Objective The majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group...
ObjectiveThe majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group frequently...
Abstract Objective The majority of individuals with femoral neck fractures opt for total hip replacement to enhance their quality of life. However, this group...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 268
SubjectTerms Aged
Aged patients
Analgesia
Analgesia, Patient-Controlled - methods
Analgesics
Anesthesia
Anxiety
Arthroplasty, Replacement, Hip - adverse effects
Blood pressure
Complications and side effects
Compression
Depression
Depression, Mental
Dizziness
Drowsiness
Drug dosages
Elderly patients
Esketamine
Femoral neck fracture
Femoral Neck Fractures
Femur
Fractures
Handedness
Hip
Humans
Immobilization
Interleukin 6
Joint replacement surgery
Ketamine
Length of stay
Medical personnel
Mental depression
Nausea
Orthopedics
Pain perception
Pain, Postoperative - etiology
Pain, Postoperative - prevention & control
Patients
Postoperative period
Quality of Life
Rehabilitation
Saline Solution
Software
Sufentanil
Total hip arthroplasty
Vomiting
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9QwFA-yJy-i-FVdJYLgQcomk7RJjqu4LIKeXNhbSNLEHVzbYdo5rH-97yWdYYqgF6_NS2ne1--FJr9HyNvAA6CGNzXW9rVMYAsngqtVSklG4X3Mvwu-fG0vr-Tn6-b6qNUXngkr9MBFcWc-cB2YcFK6JH1qTJCpc7CNiNFpeCNmX8C8_Waq5GCAdS33V2R0ezZCpua6BnyqmVAr8I0FDGW2_j9z8hEoLQ9MHiHQxUPyYC4d6Xn55EfkXuwfk1-FfpgOiY477yBxQUUHArQbxohP4_gjTu4nFJN06OkGeTQ2sdB90-2CppuuexqxafftHZ3pVkeKd8y23wcAOHqz3lDQF_ZVgJJ7untCri4-fft4Wc_9FOrQtHKqAdsbvfIxidSA6VrYHBoJBSMPSkevHWeBJ2N8AlUzr7zvVNBOybYTiRspxVNy0g99fE5o7LxLPIUuOoaM8845w3RiyUF-0KmpCN-r14Z5Fdjz4tbmTYdubTGJBZPYbBK7qsj7w5xNodr4q_QHtNpBEmmy8wNwHjs7j_2X81TkHdrcYjDD5wU330mARSItlj1H-kTTqpZV5HQhCUEYlsN7r7FzEhgtNv6CHAc1eUXeHIZxJh5s6-OwAxkk-DeCSV6RZ8XJDksSCtlelamIXrjfYs3LkX59kynCeWagbsSL_6Gll-T-KoeOhOg5JSfTdhdfQSk2-dc56n4DG8o2VA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagXLggEK9AQUZC4oCixhsntk9VQVQVEpyotDfLdux2RUnSTfZQfn1nHG9ohNRrPJY8maft8TeEfHTMQdSwKsfcPucBZGFKZ3IRQuC-tNbH64IfP-uzc_59Xa3TgduQyir3PjE66qZzeEZ-hF2UQGEgwTnur3PsGoW3q6mFxkPyCKHLsKRLrOcNFwR3yfcPZWR9NIC_ZjKHKJUXpViBhiyCUcTs_98z3wlNy7LJO3Ho9Cl5khJIejJJ_Bl54Nvn5O8EQky7QIedNeC-IK8DAtp0g8evfvjtR_MHUkratbRHNI3eT6DfdLsA66ablnps3X11QxPo6kDxpdn2ooMwRy83PQV1w-4KkHiPNy_I-em3X1_P8tRVIXdVzcccInwlV9aHMlQgwBq2iIpD2sickN5KwwrHglI2cBMKK6xthJNG8LopA1Ocly_JQdu1_jWhvrEmsOAabwrEnTfGqEKGIhjwEjJUGWH736td4gI7X1zpuPWQtZ5EokEkOopErzLyeZ7TT4Ab91J_QanNlAiWHT902wudbE9bx6QrSsOBI25DpRwPjYGdqPdGglJm5BPKXKNJw_KcSS8TgEkEx9InCKKoalEXGTlcUIIpuuXwXmt0cgWD_qe4GfkwD-NMLG9rfbcDGoT5V2XBWUZeTUo2s1QKxHwVKiNyoX4Lnpcj7eYyAoWziENdlW_uX9db8ngVjYKDXRySg3G78-8g1Rrt-2hPt-8YK88
  priority: 102
  providerName: ProQuest
Title Effect of subanesthetic dose of esketamine on postoperative rehabilitation in elderly patients undergoing hip arthroplasty
URI https://www.ncbi.nlm.nih.gov/pubmed/37009879
https://www.proquest.com/docview/2803053080
https://www.proquest.com/docview/2794693041
https://pubmed.ncbi.nlm.nih.gov/PMC10069053
https://doaj.org/article/bc18c03a44af4bf59c4fda601eea87ff
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bi9QwFA57efFFFG_VdYgg-CDVZpo2yYPIrOyyDOwi6sC8hSRNdgfHdmw74PjrPUk7ZYuL-FRoTktPzzVN830IvTbEQNXQIva9fUwd2EKlRsXMOUdtqrUNywWXV_nFgs6X2fIA7emO-hfY3Dm183xSi3r97tfP3UcI-A8h4Hn-voE8THgM1SdOUjYFyx-iY6hMzAfqJR1WFaDYBwZiaMJFzIRY7jfR3HmPUaEKeP5_Z-1bZWv8S-WtGnX-AN3vm0s867zhITqw5SP0uwMoxpXDzVYrSG3Q84EALqrG-rO2-W5b9QPaTVyVeOORNja2AwTH9QjIG69KbD2t93qHe0DWBvtdaPV1BSUQ36w2GFzRMy9AU97uHqPF-dm3Txdxz7gQmyynbQzVP-NTbV3qMjBuDtNHQaGlJIZxq7kiiSFOCO2ocolmWhfMcMVoXqSOCErTJ-iorEr7DGFbaOWIM4VVicekV0qJhLvEKcgg3GURIvvXK02vhWfFWMswLeG57EwiwSQymEROI_R2uGbTgXH8U_rUW22Q9EDa4URVX8s-LqU2hJskVRQ0otplwlBXKJilWqs4OGyE3nibS--A8HhG9bsWQEkPnCVnHmBR5CxPInQykoQwNePhvdfIvZdLTw0GWRC69gi9Gob9lf7Xt9JWW5DxFAAiTSiJ0NPOyQaVUubxYJmIEB-530jn8Ui5ugkg4iRgVGfp8_9W8AW6Nw3xQSFETtBRW2_tS-jIWj1Bh2zJJuh4Npt_ncPx9Ozq85dJ-L4xCSH4B8g1OkM
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V7QEuCMQrUMBIIA4oah5O4hwQaqHVlrYrhFqpN2M7druiJMtmV2j5UfxGZvJYGiH11ms8WWUy7439fQCvTWiwaujcp97e5w5toWKj_Mw5x22stW0-FxxP0vEp_3yWnG3An_4sDG2r7HNik6iLytB_5NvEooQOgw3Oh9lPn1ij6OtqT6HRusWhXf3Cka1-f_AJ7fsmivb3Tj6O_Y5VwDdJyhc-VrhERNq62CWoQIojUs6xbQpNJqwWKgxM6PJcO65coDOti8wIlfG0iB1O_DzG370FmzzGUWYEm7t7ky9f-9yP7YTg_dEckW7XWCFC4WNd9IM4i9AnB-WvYQn4vxZcKYbDjZpXKt_-Pbjbtaxsp_Wx-7Bhywfwu4U9ZpVj9VIrTJjYSaIAK6ra0lVbf7cL9QObWFaVbEb4HTPbwoyz-QAenE1LZoks_HLFOpjXmtHZtvl5hYWVXUxnDB2c-Byw1V-sHsLpjbzxRzAqq9I-AWYLrVzoTGFVQEj3Sqk8EC5wCvOScIkHYf96pem0IK6NS9kMOyKVrUkkmkQ2JpGRB-_W98xaiI9rpXfJamtJguduLlTzc9lFu9QmFCaIFUeNuHZJbrgrFDqMtUpgGHjwlmwuKYng4xnVnYVAJQmOS-4QbGOeZmngwdZAEoPfDJd7r5Fd8qnlv1Dx4NV6me6kDXWlrZYoQ8QCeRzw0IPHrZOtVYozQpnNcg_EwP0GOg9XyulFA00eNsjXSfz0-ud6CbfHJ8dH8uhgcvgM7kRNgHCMkS0YLeZL-xwbvYV-0UUXg283HdB_AWbdako
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+subanesthetic+dose+of+esketamine+on+postoperative+rehabilitation+in+elderly+patients+undergoing+hip+arthroplasty&rft.jtitle=Journal+of+orthopaedic+surgery+and+research&rft.au=Min%2C+Menghang&rft.au=Du%2C+Chengxu&rft.au=Chen%2C+Xiaoying&rft.au=Xin%2C+Wenqi&rft.date=2023-04-03&rft.pub=BioMed+Central+Ltd&rft.issn=1749-799X&rft.eissn=1749-799X&rft.volume=18&rft.issue=1&rft_id=info:doi/10.1186%2Fs13018-023-03728-2&rft.externalDocID=A744096760
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1749-799X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1749-799X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1749-799X&client=summon